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D eep angiomyxoma (DAM) is a very rare,  slow-growing benign tumor with a high risk of 
local recurrence after surgical resection.  This tumor is 
more common in women,  and its most common loca-
tion is the pelvic genitourinary organs [1-5].  An accu-
rate diagnosis of DAM is essential due to the local 
recurrence risk,  but the diagnosis can be difficult,  
involving challenges in clinical practice.  Herein,  we 
describe an extremely rare case of DAM in the thigh 
that was misdiagnosed as a desmoid-type fibromatosis,  
and we present a review of available literature.  The 
patient and her family were informed of our intention 
to submit the data from this case for publication,  and 
they gave their written consent.
Case Presentation
A 40-year-old Japanese woman with no history of 
any previous disease presented at our outpatient clinic 
due to a mass and slight pain on her left thigh that had 
persisted for 3 months.  Physical examinations revealed 
a small,  hard lump on the inside of the left thigh.  
Magnetic resonance imaging showed a large tumor 
(max.  dia.  187 mm) spreading subcutaneously inside 
the thigh.  The tumor showed iso-signal intensity on 
T1-weighted images (Fig. 1A) and low-to-high intensity 
on T2-weighted images (Fig. 1B, C).  To exclude soft 
tissue sarcoma,  we performed a needle biopsy to sam-
ple the tumor,  and in the histopathological examina-
tion,  a mild proliferation of spindle-shaped cells with 
poor atypia was observed against the background of a 
fibrous substrate; vascular intervention and some 
mature adipose tissue were also observed (Fig. 2A).  In 
immunohistochemical staining,  vimentin was positive,  
smooth muscle actin (SMA) was partially positive,  
CD34 was negative,  and the positive rate of Ki-67 was 
1-2%.  β-catenin was confirmed to be positive in both 
the nucleus and cytoplasm in some spindle-shaped cells 
(Fig. 2B).  The diagnosis of desmoid-type fibromatosis 
was thus made.
Internal medicines of tranilast (300 mg/day) and 
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meloxicam (10 mg/day) were prescribed to the patient.  
However,  the tumor showed a tendency to gradually 
grow.  Another needle biopsy was performed 9 months 
after the patient’s first visit,  but the pathological find-
ings were similar to those previously collected.  The 
patient did not want to have the tumor removed surgi-
cally,  and she continued taking tranilast and meloxi-
cam.  The tumor continued to grow slowly (Fig. 3A , B),  
and at 4 years after her first visit the patient requested 
surgical resection.
We resected the tumor extensively and reconstructed 
the surface layer with skin grafting (Fig. 4).  The histo-
pathological examination revealed that the tumor area 
was covered with a fibrous capsule at the margin,  and 
no infiltration into fat or muscle tissue was observed.  
The inside of the tumor was mostly a wavy and bun-




Fig. 1　 MRI with axial views of T1-weighted (A) and T2-weighted (B) images and a coronal view of a T2-weighted image (C). The tumor 
reveals iso-signal intensity on T1-weighted images and low-to-high intensity on T2-weighted images.
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Fig. 2　 Histopathological findings from a needle biopsy from the thigh tumor are visualized with hematoxylin and eosin (H&E) staining 
(A) and immunohistochemical staining of β-catenin (B). The histopathological examination revealed a mild proliferation of spindle-shaped 
cells with poor atypia against the background of a fibrous substrate (A). β-catenin was confirmed to be positive in both the nucleus and 
cytoplasm in some spindle-shaped cells (B).
dle-like growth of sparse spindle-shaped cells,  with the 
invasion of capillaries and collagen fibers; atypical and 
mitotic figures were not observed inside the tumor 
(Fig. 5A).  In immunohistochemical staining,  vimentin,  
SMA,  desmin,  estrogen receptor,  and progesterone 
receptor were positive,  CD34 was partially positive,  
and the positive rate of Ki-67 was < 1%.  In addition,  
high mobility group AT-hook 2 (HMGA2) was slightly 
positive (Fig. 5B).  However,  β-catenin was negative 
(Fig. 5C).  Based on these histological features,  a con-
ference of multiple pathologists arrived at the consensus 
diagnosis of DAM.
The postoperative course was uneventful,  and the 
patient walked without pain.  She has not noticed any 
local recurrence as of the most recent follow-up,  
16 months post-operatively.
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Fig. 3　 MRI axial view (A) and coronal view (B) of T2-weighted (B) images. The tumor continues to grow.
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Fig. 4　 Intraoperative photographs. The tumor presented as a small, hard lump on the inside of the patient's left thigh (A), and the tumor 
was extensively resected (B,C). We reconstructed the surface layer with skin grafting (D).
Discussion
The first report of DAM was provided in 1983 by 
Steeper and Rosai [1],  and this tumor has been 
reported to be a rare benign mesenchymal tumor.  
DAM generally occurs in the reproductive organs of 
women,  and it is most common in the vulva and pelvic 
cavity [2-5].  However,  in a few cases,  DAM has 
occurred in the testes and spermatic cords of men [6 , 7].  
Most DAM tumors occur in the pelvis,  and there are 
few reports of tumors occurring in a lower extremity,  as 
in our patient’s case.  Heffernan et al. reported a case of 
DAM that developed subcutaneously in the proximal 
thigh [8],  and Zou et al. described 27 cases of DAM,  
two of which were in the lower limbs,  including the 
knee [5].  There are reports of various sites of the occur-
rence of superficial angiomyxomas,  such as in the lower 
extremities [9 , 10].  Although the term ‘superficial angi-
omyxoma’ sounds similar to ‘deep angiomyxoma 
(DAM),’ it is an entirely different disease from DAM.  
There are only three prior reports of DAM at a lower 
extremity,  as a very rare site of occurrence; the diag-
nosis in our patient’s case was a challenge.  We may 
need to consider the possibility of DAM not only in the 
pelvis but also around the pelvis.
The diagnosis of DAM based on imaging alone is 
difficult,  and an evaluation using a sufficient amount of 
tissue is required [11].  Clinically,  DAM may be mis-
taken for a lipoma,  vulvar abscess,  or Gartner’s duct 
cyst; however,  even with a histological diagnosis,  it 
may be difficult to distinguish DAM from other myxoid 
neoplasms such as myxoid liposarcoma [12 , 13].  It is 
thus often difficult to make the correct diagnosis even 
when a histological examination is performed,  and the 
misdiagnosis rate for DAM is reported to be 25.9-82% 
[2 , 5].  In our patient’s case,  the initial diagnosis was 
desmoid-type fibromatosis; however,  there are no pre-
vious reports stating that a DAM was mistaken for des-
moid-type fibromatosis.  We found that the partial 
positivity of β-catenin confirmed in the tissue used in 
our patient’s first needle biopsy had significant influence 
in the diagnosis.  DAM is stained with immunostaining 
markers such as vimentin,  desmin,  CD34,  estrogen 
receptor,  and progesterone receptor,  but there have 
been no reports on β-catenin in DAM.  In our patient,  
no positive image was confirmed in the tissue after exci-
sion; thus,  it is most likely that DAM is basically 
unstained,  and this was observed in our patient’s case.
The HMGA2 gene encodes a protein that alters the 
chromatin structure and regulates the transcription of 
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Fig. 5　 Histopathological findings of the excised tumor: H&E staining (A). Immunohistochemical staining of high mobility group AT-hook 
2 (HMGA2) (B) and β-catenin (C). In the histopathology, the inside of the tumor was mostly a wavy and bundle-like growth of sparse 
spindle-shaped cells and the invasion of capillaries and collagen fibers, and atypical and mitotic figures were not noticeable inside the 
tumor (A). HMGA2 staining was sparsely positive (B). However, β-catenin was negative (C).
several genes.  Rearrangements of the HMGA2 gene are 
a characteristic feature of the development of several 
mesenchymal tumors.  Several studies have reported 
that rearrangements of the HMGA2 gene are strongly 
associated with a high probability of developing DAM 
[14 , 15].  HMGA2 expression was confirmed in our 
patient’s case,  showing that the assessment of this gene 
is a useful indicator for the diagnosis of DAM.
Desmoid-type fibromatosis is generally referred to as 
one of the most difficult tumors to diagnose,  and there 
is sometimes a change in a diagnosis from before to 
after an excision.  Kasper reported a misdiagnosis rate 
of 30-40% in desmoid-type fibromatosis [16].  There are 
many cases of mutations in CTNNB1 in desmoid-type 
fibromatosis; CTNNB1 is a β-catenin gene,  and the 
analysis of these gene mutations can improve the accu-
racy of diagnosis [17].  It may be advisable to conduct 
such an analysis in cases in which desmoid-type fibro-
matosis is suspected,  in order to prevent a misdiagno-
sis.
In conclusion,  we have presented an extremely rare 
case of DAM on the thigh that was misdiagnosed as 
desmoid-type fibromatosis.  Although DAM in a lower 
extremity is extremely rare,  clinicians must be aware of 
its possible occurrence at body sites that are relatively 
close to the pelvis.
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